Cargando…
Study on Dalfampridine in the treatment of Multiple Sclerosis Mobility Disability: A meta-analysis
OBJECTIVE: Systematic Review was used to evaluate the efficacy and safety of Dalfampridine (DAP) in the treatment of Mobility Disability (MS) in patients with Multiple Sclerosis. METHODS: Clinical randomized controlled studies about DAP and placebo in the treatment of Mobility Disability in patients...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742383/ https://www.ncbi.nlm.nih.gov/pubmed/31513613 http://dx.doi.org/10.1371/journal.pone.0222288 |